SIC
HQL

Salem Investment Counselors’s abrdn Life Sciences Investors HQL Stock Holding History

Salem Investment Counselors’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.5K Hold
125
– – ﹤0.01% 1085
2026
Q1 		$2.03K Buy
+125
New +$2.09K ﹤0.01% 1078
2025
Q4 		– Sell
-125
Closed -$1.94K – 721
2025
Q3 		$1.94K Hold
125
– – ﹤0.01% 1074
2025
Q2 		$1.6K Hold
125
– – ﹤0.01% 1057
2025
Q1 		$1.59K Hold
125
– – ﹤0.01% 1064
2024
Q4 		$1.74K Hold
125
– – ﹤0.01% 1037
2024
Q3 		$1.89K Hold
125
– – ﹤0.01% 1040
2024
Q2 		$1.77K Hold
125
– – ﹤0.01% 1031
2024
Q1 		$1.7K Hold
125
– – ﹤0.01% 1050
2023
Q4 		$1.68K Buy
+125
New +$1.54K ﹤0.01% 1000

Other funds holding HQL

FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
UPS
UHLMANN PRICE SECURITIES Skokie, Illinois $2.68B AUM 149.5% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $476M AUM
SI
Stephens Inc Little Rock, Arkansas $8.93B AUM 25.13% 1-Year Est. Return
CEFA
Closed-End Fund Advisors Richmond, Virginia $102M AUM
KAS
KPP Advisory Services Louisville, Kentucky $791M AUM 28.5% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Salem Investment Counselors's HQL Position: Q2 2026 in Review

Salem Investment Counselors held its abrdn Life Sciences Investors (HQL) position steady in Q2 2026 at 125 shares worth $2.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1085.

Salem Investment Counselors first reported a position in HQL in Q4 2023 and has held it in 10 quarters since. 34 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

  • Salem Investment Counselors held 125 shares of abrdn Life Sciences Investors worth $2.5K as of Q2 2026.
  • Salem Investment Counselors left its abrdn Life Sciences Investors share count unchanged in Q2 2026.
  • abrdn Life Sciences Investors made up ﹤0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #1085 holding.
  • Salem Investment Counselors first reported a position in abrdn Life Sciences Investors in Q4 2023 and has held it in 10 quarters since.
  • 34 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.